Collected fees will be used to expedite the review process of biosimilar biological product applications, including post-market safety activities.

FORBES: PDUFA: One of Congress' most important health policy votes in 2012

Biological, medical and other social sciences have also found applications for their work.

ECONOMIST: Economics focus